These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31743688)

  • 1. Trypanosoma brucei: Inhibition of cathepsin L is sufficient to kill bloodstream forms.
    Steverding D; Rushworth SA; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2020 Jan; 235():111246. PubMed ID: 31743688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei: β2-selective proteasome inhibitors do not block the proteasomal trypsin-like activity but are trypanocidal.
    Steverding D; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2019 Jan; 227():1-4. PubMed ID: 30444977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target.
    Steverding D; Sexton DW; Wang X; Gehrke SS; Wagner GK; Caffrey CR
    Int J Parasitol; 2012 May; 42(5):481-8. PubMed ID: 22549023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei.
    Mackey ZB; O'Brien TC; Greenbaum DC; Blank RB; McKerrow JH
    J Biol Chem; 2004 Nov; 279(46):48426-33. PubMed ID: 15326171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
    Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
    Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei.
    Troeberg L; Morty RE; Pike RN; Lonsdale-Eccles JD; Palmer JT; McKerrow JH; Coetzer TH
    Exp Parasitol; 1999 Apr; 91(4):349-55. PubMed ID: 10092479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide inhibits the lysosomal cathepsin b-like protease and kills African trypanosomes.
    Unciti-Broceta JD; Maceira J; Morales S; García-Pérez A; Muñóz-Torres ME; Garcia-Salcedo JA
    J Biol Chem; 2013 Apr; 288(15):10548-57. PubMed ID: 23443665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
    Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided development of selective TbcatB inhibitors.
    Mallari JP; Shelat AA; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    J Med Chem; 2009 Oct; 52(20):6489-93. PubMed ID: 19769357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
    Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
    Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei.
    Steverding D; da Nóbrega FR; Rushworth SA; de Sousa DP
    Parasitol Res; 2016 Nov; 115(11):4397-4403. PubMed ID: 27535679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate inhibition and allosteric regulation by heparan sulfate of Trypanosoma brucei cathepsin L.
    Costa TF; dos Reis FC; Lima AP
    Biochim Biophys Acta; 2012 Mar; 1824(3):493-501. PubMed ID: 22234330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors.
    Steverding D; Spackman RW; Royle HJ; Glenn RJ
    Parasitol Res; 2005 Jan; 95(1):73-6. PubMed ID: 15578221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.
    Abdulla MH; O'Brien T; Mackey ZB; Sajid M; Grab DJ; McKerrow JH
    PLoS Negl Trop Dis; 2008 Sep; 2(9):e298. PubMed ID: 18820745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proteasome activity blocks cell cycle progression at specific phase boundaries in African trypanosomes.
    Mutomba MC; To WY; Hyun WC; Wang CC
    Mol Biochem Parasitol; 1997 Dec; 90(2):491-504. PubMed ID: 9476796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on relevant trypanosome peptidases: Validated targets and future challenges.
    Alvarez VE; Iribarren PA; Niemirowicz GT; Cazzulo JJ
    Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140577. PubMed ID: 33271348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a multicatalytic proteinase complex (20S proteasome) from Trypanosoma brucei brucei.
    Lomo PO; Coetzer TH; Lonsdale-Eccles JD
    Immunopharmacology; 1997 Jun; 36(2-3):285-93. PubMed ID: 9228559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.